Pharma&Chemical Reviewsp. z o.o.
Other out-of-school forms of education, not elsewhere classified
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 2 of 3 financial statements were filed late (the longest delay 360 days for 2021).
- 2023not filed
- 202210/07/2023
- 202110/07/2023
- 202025/08/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Results vs industry
Industry
Public procurement
Pharma&Chemical Review is the contractor in 4 public sector contracts, worth USD 1.27k in total. They were signed with 2 public buyers. The largest number (3) were signed with Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych I Produktów Biobójczych.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 1, 2026 | Individual training “PRZEWODNIK PO WYTYCZNYCH ICH Q (QUALITY): STANDARDY ŚWIATOWE” | $534.85 | Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych I Produktów Biobójczych | |
| Aug 4, 2026 | Training | $148.57 | Powiatowy Inspektorat Weterynarii Nowa Sól | |
| Jul 17, 2026 | Individual training entitled GMP for the medicinal products under study | $294.44 | Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych I Produktów Biobójczych |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations in the name of the company are made by a member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations in the name of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Ławrynowiczage 48 | 30 | $405.19 | 30% |
Piotr Andrzej Marzecage 50 | 70 | $945.43 | 70% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Sunenergy 1sp. z o.o. | 1,350.62 USD | 100% | ||
Sunenergy 3sp. z o.o. | 1,350.62 USD | 100% | ||
Uniin.Eusp. z o.o. | 1,350.62 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2019-09-01.
38 1870 1045 2078 1088 0062 0001
60 1020 1185 0000 4302 0309 5577
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kaizen Yourselfsp. z o.o. | $126,853.68 | kaizenyourself.pl | ||
| Grupa Fundamentisp. z o.o. | $120,703.65 | fundamenti.pl | ||
| Diameo Anna Beczek, Wojciech Łojansp. j. | $119,762.71 | diameo.pl | ||
| Bowartosp. z o.o. | $112,829.67 | bowarto.com | ||
| UHY Eca Szkoleniasp. z o.o. | $112,022.97 | uhy-pl.com | ||
| Intrafonsp. z o.o. | $110,783.62 | intrafon.pl | ||
| Henderson Consulting Polskasp. z o.o. | $108,943.48 | henderson-polska.pl | ||
| ASK Akademia Szkoleńsp. z o.o. | $103,620.46 | askakademia.com | ||
| Robotics Eventssp. z o.o. | $103,025.17 | konstruktor.edu.pl | ||
| AI It Solutions Pozsp. z o.o. | $101,479.25 | poznan.itstep.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-09-30 | Address change (Ul. Rogalińska 1/35, 01-206, Warszawa → Ul. Rozłucka 12/15, 04-029, Warszawa) | |
| 2021-03-29 | Name change (Pharma Review Innovations → Pharma&chemical Review) | |
| 2021-03-29 | PKD change (Removed: 8 codes; Added: 4 codes) | |
| 2020-05-08 | Name change (Sunenergy 2 → Pharma Review Innovations) | |
| 2020-02-18 | Address change (Ul. Stanisława Leszczyńskiego 4/25, 50-078, Wrocław → Ul. Rogalińska 1/35, 01-206, Warszawa) |
FAQ
Last updated: 2026-04-13